Guler R,
Agacayak KS.The evaluation of the effect of long-term antihypertensive drug
usage on bone density with dental volumetric tomography. J Clin Exp Dent.
2024;16(2):e172-7.
doi:10.4317/jced.61240
https://doi.org/10.4317/jced.61240
_______
References
|
1.
Kjeldsen S, Feldman RD, Lisheng L, Mourad JJ, Chiang WZ, Zhang W, et al.
Updated national and international hypertension guidelines: a review of
current recommendations. Drugs. 2014;74:2033-51. |
|
|
|
|
|
2.
Laurent S. Antihypertensive drugs. Pharmacological Research. 2017;124:116-125. |
|
|
|
|
|
3.
Clynes MA, Harvey CN, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The
epidemiology of osteoporosis. British Medical Bulletin. 2020;133:105-117. |
|
|
|
|
|
4.
Henry MJ, Pasco JA, Nicholson GV, Kotowicz MA. Prevalence of osteoporosis in
Australian men and women: geelong Osteoporosis. Study. Med J Aust. 2011;195:321-322. |
|
|
|
|
|
5.
Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug
treatments on fracture outcomes: a meta-analysis of observational studies. J
Intern Med. 2006;260:350-62. |
|
|
|
|
|
6.
Massimo Varenna M, Manara L, Galli L, Binelli L, Zucchi F, Sinigaglia L. The
Association Between Osteoporosis and Hypertension: The Role of A Low Dairy
Intake. Calcif Tissue Int. 2013;93:86-92. |
|
|
|
|
|
7.
Chun KJ. Bone Densitometry. Semin Nucl Med. 2011;41:220-8. |
|
|
|
|
|
8.
Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol. 1997;26:3-15. |
|
|
|
|
|
9.
Carrafiello G, Dizonno M, Colli V, Strocchi S, Taubert SP, Leonardi A, et al.
Comparative study of jaws with multislice computed tomography and cone-beam
computed tomography. Radiol Med. 2010;115:600-611. |
|
|
|
|
|
10.
Agaçayak KS, Güven S, Koparal M, Gunes N, Atalay Y, Atılgan S. Long-term
effects of antihypertensive medications on bone mineral density in men older
than 55 years. Clinical Interventions in Aging. 2014;9:509-13. |
|
|
|
|
|
11.
Hohlweg-Majert B, Pautke C, Deppe H, Metzger MC, Wagner K, Schulze D.
Qualitative and quantitative evaluation of bony structures based on DICOM
dataset. J Oral Maxillofac Surg. 2011;69:2763-2770. |
|
|
|
|
|
12.
González-Martín O, Lee EA, Veltri M. CBCT fractal dimension changes at the
apex of immediate implants placed using under sized drilling. Clin Oral
Implants Res. 2012;23:954-957. |
|
|
|
|
|
13.
Lee K, Taguchi A, Ishii K, Suei Y, Fujita M, Nakamoto T, et al. Visual
assessment of the mandibular cortex on panoramic radiographs to identify
postmenopausal women with low bone mineral densities. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2005;100:226-231. |
|
|
|
|
|
14.
Taguchi A, Suei Y, Sanada M, Ohtsuka M, Nakamoto T, Sumida H, et al.
Validation of dental panoramic radiography measures for identifying
postmenopausal women with spinal osteoporosis. Am J Roentgenol. 2004;183:1755-1760. |
|
|
|
|
|
15.
Schreiber JJ , Anderson PA, Rosas HG, Buchholz AL, Au AG. Hounsfield units
for assessing bone mineral density and strength: a tool for osteoporosis
management. J Bone Joint Surg Am. 2011;93:1057-63. |
|
|
|
|
|
16.
Ağaçayak KS, Güler R, İlyasov B. Evaluation of the effect of long-term use of
antidepressants in the SSRI group on bone density with dental volumetric
tomography. Drug Design, Development and Therapy. 2019;13:3477-3484. |
|
|
|
|
|
17.
Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between
hypertension and fragility fracture: a longitudinal study. Osteoporos Int.
2014;25:97-103. |
|
|
|
|
|
18.
Ilić K, Obradović N,
Vujasinović-Stupar N. The relationship among hypertension, antihypertensive
medications, and osteoporosis: a narrative review. Calcif Tissue Int.
2013;92:217-27. 19.
Kang KY, Kang Y, Kim M, Kim Y, Yi H, Kim J, et al. The effects of
antihypertensive drugs on bone mineral density in ovariectomized mice. J
Korean Med Sci. 2013;28:1139-1144. |
|
|
|
|
|
20.
Özdemir F, Tastek N, Zateri C. The Effect On Bone-Mineral Density of
Perindopril As An Antihypertensive Drug in Osteoporosis Patients. Turkiye
Klinikleri J Med Sci. 2006;26:375-379. |
|
|
|
|
|
21.
Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JA. Mortality risk
associated with low-trauma osteoporotic fracture and subsequent fracture in men
and women. JAMA. 2009;301:513-5. |
|
|
|
|
|
22.
Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, et.
al. Protective effect "of β blockers in postmenopausal women: Influence
onfractures, bone density, micro and macroarchitecture. Controlled Clinical
Trial Bone. 2007;40:1209-16. |
|
|
|
|
|
23.
Barzilay JI, Davis BR, Pressel SL, Ghosh A, Puttnam R, Margolis KL, et al.
The Impact of Antihypertensive Medications on Bone Mineral Density and
Fracture Risk. Curr Cardiol Rep. 2017;19:76. |
|
|
|
|
|
24.
Pasco JA, Henry MJ, Sanders KM. Beta-Adrenergic Blockers Reduce the Risk of
Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis
Study. J Bone Miner Res. 2004;19:19-24. |
|
|
|
|
|
25.
Lynn H, Kwok T, Wong SYS, Woo J, Leung PC. Angiotensin converting enzyme
inhibitor use is associated with higher bone mineral density in elderly
Chinese. Bone. 2006;38:584-588. |
|